PROHANCE 279,3 mg/ml SOLUCION INYECTABLE
PROHANCE 279,3 mg/ml SOLUCION INYECTABLE
Commercialized
Register Number
60377
Prescription Type
Uso Hospitalario Y Centros De Diagnóstico Autorizados
Authorization Date
Nov 30, 1998
Dosage Form
SOLUCIÓN INYECTABLE
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number60377
EMA Approved
No
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
GADOTERIDOLActive
Quantity: 279,3 mg
Name: GADOTERIDOL
ATC CLASSIFICATION (3)
V08C
V08CA
V08CA04